"Clínica Las Condes de Santiago de Chile cuenta con los mejores especialistas y tecnología, garantizando consultas ambulatorias y tratamientos de excelencia. Servicio de Urgencia 24 horas"

During the past decade, Clinica Las Condes conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica Las Condes" #1 sponsor was "Clinica las Condes, Chile" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Clínica Las Condes. LIT INNOVA CORFO" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Las Condes" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Corporacion de ayuda al niño quemado (COANIQUEM)" with 1 trials as a collaborator, "Latin American Cooperative Oncology Group" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Las Condes" are "ARDS" (2 trials), "Multiple Sclerosis" (2 trials), "Bipolar I Disorder" (1 trials), "Breast Cancer" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "Clinica Las Condes" in a lesser frequency.

Most popular intervention types in "Clinica Las Condes" are "Drug" (12 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ado-trastuzumab emtamsine" (1 trials), "Asacol" (1 trials), "Atezolizumab" (1 trials) and "Autologous Mesenchymal Stem Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Las Condes" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Las Condes". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Clinica Las Condes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Las Condes, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".